7,9- difluoro- 5- (4- (2- piperidin- 1- ylethoxy)phenyl)- 5H- 6- oxachrysen- 2- ol

an estrogen receptor modulator that binds both ERalpha and ERbeta receptors; may be useful in the treatment of hot flushes; structure in first source

Also Known As:

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Adrian, Mary D: 1 article (02/2006)
2.	Bryant, Henry U: 1 article (02/2006)
3.	Burris, Thomas P: 1 article (02/2006)
4.	Calvin, Joel R: 1 article (02/2006)
5.	Dodge, Jeffrey A: 1 article (02/2006)
6.	Geiser, Andrew G: 1 article (02/2006)
7.	Hinklin, Ronald: 1 article (02/2006)
8.	Lauwers, Kenneth S: 1 article (02/2006)
9.	May, Scott A: 1 article (02/2006)
10.	Sato, Masahiko: 1 article (02/2006)

Related Diseases

1.	Uterine Neoplasms (Uterine Cancer) 02/09/2006 - "(R)-(+)-7,9-difluoro-5-[4-(2-piperidin-1-ylethoxy)phenyl]-5H-6-oxachrysen-2-ol, LSN2120310, potently binds ERalpha and ERbeta and is an antagonist in MCF-7 breast adenocarcinoma and Ishikawa uterine cancer cell lines. "
2.	Adenocarcinoma 02/09/2006 - "(R)-(+)-7,9-difluoro-5-[4-(2-piperidin-1-ylethoxy)phenyl]-5H-6-oxachrysen-2-ol, LSN2120310, potently binds ERalpha and ERbeta and is an antagonist in MCF-7 breast adenocarcinoma and Ishikawa uterine cancer cell lines. "

Related Drugs and Biologics

1.	Estrogen Receptor beta
2.	Estrogen Receptor alpha